Abridged  CV
SELECT PEER-REVIEWED PUBLICATIONS:

-     Faguet GB:
Quantitation of immunocompetence in Hodgkin's Disease. J. Clin. Invest. 56:951-957,1975

-     Faguet GB: Mechanisms of lymphocyte activation: I Binding kinetics of phytohemaglutinin to human lymphocytes. J. Biol. Chem. 252:2095-2100,1977

-     Faguet GB, Barton BB, Smith LL, Garver FA: Gamma Heavy chain disease: CLinical aspects and characteristics of a deleted, non-covalently linked y1 Heavy Chain Dimer (BAZ). Blood 49;
495-505,1977.

-     Faguet GB, Barton BP, Smith LL, Garver FA. Gamma heavy chain disease: Clinical aspects and characterization of a deleted noncovalently linked gamma-1 heavy chain dimer (BAZ) Blood
1977;49:495-505

-     Faguet GB:  Mechanisms of lymphocyte activation. The role of suppressor cells in the proliferative responses of chronic lymphocytic leukemia lymphocytes. J. Clin. Invest. 63:67-74,1979

-     Faguet GB: Leukoagglutinin binding to human lymphocytes. Experimental support for negatively interacting binding sites. Am. J. Physiol 237(3):E207-E213,1979

-     Faguet GB: The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes. J. Infect. Dis. 143(2):252-258,1981

-     Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 58:916-919,1981

-     Faguet GB, Davis HC:  Survival in Hodgkin's disease: The role of immunocompetence and other major risk factors. Blood 59(5):938-945,1982

-     Faguet GB, Davis HC. Regression analysis in medical research. Southern Med J 1984;77(6):722-729..

-     Faguet GB:  Ligand-receptor interactions: Detailed evaluation of occupancy-dependent affinity. J. Cell. Biochem. 31:75-86,1986

-     Faguet GB:  Number of receptor sites from Scatchard and Klotz graphs: Valid and complementary approaches. J. Cell. Biochem. 31:243-250,1986

-     Faguet GB, Beebe DP:  Binding interaction studies of selected receptor subpopulations after partial cross-linking receptor-ligand complexes with a photo-activated heterobifunctional reagent.
J. Clin. Invest. 7
8:67-72,1986

-     Faguet GB, Beebe DP: Nutritional requirements of human malignant (leukemia) cell lines: Implications for adjuvant therapy. Cancer Res. 1:2380-2384,1987

-     Faguet GB, Agee JF: Monoclonal antibodies against the chronic lymphocytic leukemia antigen cCLLa: Characterization and Reactivity. Blood 70:437-443,1987

-     Faguet GB, Satya-Prakash KL, Agee JF: Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines. Blood 71:422-429,1988

-     Faguet GB, Agee JF: Transplantation of human hairy cell leukemia in radiation-preconditioned nude mice: Characterization by histologic, histochemical, phenotypic, and tumor kinetic studies.
Blood 71:
1511-1517,1988

-     Faguet GB, Agee JF: Immunophenotypic diagnosis of clinical and preclinical chronic lymphocytic leukemia (CLL) using monoclonal antibodies against the cCLLa, a CLL-associated antigen.
Blood 72:679-684,1988

-     Faguet GB: Common chronic lymphocytic leukemia antigen (cCLLa). Distribution, fate and clinical applications. Nouv. Rev. Fr. Hematol. 30:305-310,1988

-     Faguet GB, Agee JF: Modulation, shedding and serum titers of the chronic lymphocytic leukemia-associated antigen (cCLLa): Characterization and clinical correlations.Blood 74:2493-
2500,1989

-     Faguet GB, Agee JF: Blood kinetics, tissue distribution; and radioimaging of anti-common chronic lymphatic leukemia antigen (cCLLa) monoclonal antibody CLLé in mice transplanted with
cCCLLa-bearing human leukemia cells.
Blood 1990;75:1853-1861.

-     Faguet GB,
Agee JF:  Modulation, shedding and serum titers of the chronic lymphocytic leukemia-associated antigen (cCLLa): Characterization and clinical correlations Blood 75:114-
122,1990

-     Faguet GB, Agee JF, and Marti GE: Clone emergence and evolution in chronic lymphocytic leukemia: characterization of clinical, laboratory and immunophenotypic profiles in 25 patients.
Leukemia & Lymphoma6:335-344,1992

-     Faguet GB, Agee JF, Marti GE: CD5 and cCLLa expression in chronic lymphocytic leukemia (CLL): Demonstration of their relative prevalence and that of other common B-CLL markers.
Leukemia & Lymphoma6:345-356,1992

-     Faguet GB, Marti GE, Agee JF, Bertin P: CD5 positive and negative B-CLL: Evidence supporting phenotypic heterogeneity in B-chronic lymphocytic leukemia (B-CLL). Ann NY Acad Sci 651:
470-473,1992

-     Marti GE, Faguet GB, Bertin P, Agee JF, Washington GC, Ruiz S, Carter P, Zenger v, Vogt R, Noguchi PD.  CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann NY Acad Sci
651:480-483,1992

-    Faguet GB, Agee JF: Four Ricin chain A-based immunotoxins directed against the common chronic lymphocytic leukemia antigen (cCLLa): In vitro characterization. Blood 82: 536-543,1993

-     Faguet GB, Agee JF: A simple technique for the rapid enrichment of class and subclass hybridoma switch variants:  A 1000-fold enrichment in half the time, for half the cost. J Immunol
Methods 165:217-224,1993

-     Faguet GB:  Chronic Lymphocytic Leukemia:  An updated review. J Clin Oncol 12:1974-1990,1994

-     Faguet GB:  Hodgkin's disease:  Basing treatment decisions on prognostic factors. Leukemia & Lymphoma 17:223-238,1995

-     Faguet GB, Agee JF: The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target:  Pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in
xenografted athymic mice.
Leukemia and Lymphoma 25:509-520,1997

-     Faguet GB, Agee JF: The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: Assessment of LD50 and MTD of four ricin-based anti-cCLLA immonotoxins in xenografted
athymic mice.
Leukemia and Lymphoma 25:531-537,1997

-     Faguet GB: A brief history of cancer: Age-old milestones underlying our current knowledge database. Int J Cancer 136;2022-2036,2014.

-     Faguet GB: Quality of End-of-Life care: An overdue imperative.
Critical Reviews in Oncology/Hematology. 2016;108:69-72.

-     Faguet GB. Can we trust everything we read? - Let the reader beware (publication pending)


BOOKS

Edited:
-        Hematologic Malignancies: Methods and TechniquesThe Humana Press, Inc. Totowa, NJ, USA, November 2000
 -  Purchase online  

-        Chronic Lymphocytic Leukemia: Molecular genetics, Biology, Diagnosis, and Management  The Humana Press, Inc., November 2003.
Purchase online

Authored:
-        The War on Cancer: An anatomy of failure; A blueprint for the future  Springer, Dordrecht, The Netherlands. November 2005.  -  
Purchase online

-        Pain Control and Drug Policy: A Time for Change  Praeger, Santa Barbara, CA, USA, April 2010.  -  Purchase online   
-        The Affordable Care Act: A missed opportunity; A better way forward Algora, York, NY, April 2013.  -  Purchase online

-        The Conquest of Cancer: A distant goal. Springer, Dordrecht, The Netherlands. December 2014.  Purchase online        
-                 Chapter 8:
Complementary and alternative Medicine.

-        A Life Journey: Memories. Expected publication expected in 2019.

-        Are scholarly publications credible? The facts. Expected Publication in 2020.

GRADUATE & POST-GRADUATE EDUCATION                         
    Universidad Javeriana Medical School, Bogota, Colombia
•     Internship: Hamilton Civic Hospitals (McMaster Unit). Hamilton, ON, Canada        
•     Medicine Residency; University of Texas Medical Branch, Galveston, TX                        
•     Hematology-Oncology fellowship; Ohio State University, Columbus, OH
                                                                  
INSTITUTIONAL AFFILIATIONS AND RANK
    Georgia Regents University; Professor of Medicine
•     VA Medical Center; Director, Cancer Immunology & Flow Cytometry Laboratories
                                                                              
PAST PROFESSIONAL SOCIETY MEMBERSHIP:
•     American Society of Hematology
•     International Society Hematology
•     American Association of Immunologists
•     American Federation for Clinical Research
•     New York Academy of Sciences
•     Southern Medical Association
•     Southern Society for Clinical Investigation

PAST COOPERATIVE STUDY GROUP MEMBERSHIP                             
    Polycythemia Vera Study Group    
•     Southeastern Cancer Study Group

AD HOC GRANT REVIEWER & CONSULTANT
•     National Institute of Health                           
•     National Science Foundation                      
•     Department of Veterans Affairs
•     American Cancer Society

AD HOC MEDICAL JOURNAL REVIEWER:                                                                  
•     Blood   
•     British Medical Journal   
•     Canadian J of Biochemistry
•     Cancer Research
•     European Journal of Cancer
•     Journal of Clinical Investigation                  
•     Journal of Infectious Diseases      
•     Journal of Membrane Biology
•     Journal of the National Cancer Institute